- Home
- SIG vs ALVO Comparison
SIG vs ALVO Comparison
Compare SIG & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIG
- ALVO
- Stock Information
- Founded
- SIG 1950
- ALVO 2013
- Country
- SIG Bermuda
- ALVO Luxembourg
- Employees
- SIG N/A
- ALVO N/A
- Industry
- SIG Consumer Specialties
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- SIG Consumer Discretionary
- ALVO Health Care
- Exchange
- SIG Nasdaq
- ALVO Nasdaq
- Market Cap
- SIG 2.2B
- ALVO 2.5B
- IPO Year
- SIG N/A
- ALVO N/A
- Fundamental
- Price
- SIG $64.40
- ALVO $9.68
- Analyst Decision
- SIG Buy
- ALVO Buy
- Analyst Count
- SIG 4
- ALVO 1
- Target Price
- SIG $69.00
- ALVO $18.00
- AVG Volume (30 Days)
- SIG 935.2K
- ALVO 166.0K
- Earning Date
- SIG 06-03-2025
- ALVO 05-07-2025
- Dividend Yield
- SIG 1.99%
- ALVO N/A
- EPS Growth
- SIG N/A
- ALVO N/A
- EPS
- SIG N/A
- ALVO 0.34
- Revenue
- SIG $6,703,800,000.00
- ALVO $587,890,000.00
- Revenue This Year
- SIG $0.64
- ALVO $33.92
- Revenue Next Year
- SIG $1.26
- ALVO $45.74
- P/E Ratio
- SIG N/A
- ALVO $28.56
- Revenue Growth
- SIG N/A
- ALVO 413.92
- 52 Week Low
- SIG $45.55
- ALVO $7.35
- 52 Week High
- SIG $112.06
- ALVO $14.65
- Technical
- Relative Strength Index (RSI)
- SIG 65.50
- ALVO 61.68
- Support Level
- SIG $59.90
- ALVO $7.90
- Resistance Level
- SIG $65.62
- ALVO $8.50
- Average True Range (ATR)
- SIG 2.25
- ALVO 0.42
- MACD
- SIG 0.59
- ALVO 0.25
- Stochastic Oscillator
- SIG 90.15
- ALVO 73.72
About SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.